Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression-Reference-Cited by-同舟云学术

Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression

Published:2018-07-12 Issue:3 Volume:101 Page:291-296
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Wang Wen-Jun¹,Zheng Chao-Feng¹,Liu Zhuang¹,Tan Yan-Hong¹,Chen Xiu-Hua¹,Zhao Bin-Liang²,Li Guo-Xia¹,Xu Zhi-Fang¹,Ren Fang-Gang¹,Zhang Yao-Fang¹,Chang Jian-Mei¹,Wang Hong-Wei¹^ORCID

Affiliation:

1. Department of Hematology; The Second Hospital of Shanxi Medical University; Taiyuan Shanxi China

2. School of Public Health; Shanxi Medical University; Taiyuan Shanxi China

Funder

Shanxi Scholarship Council of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13084/fullpdf

Reference28 articles.

1. BCR-ABL PCR testing in chronic myelogenous leukemia: molecular diagnosis for targeted cancer therapy and monitoring;Luu;Expert Rev Mol Diagn,2013

2. Diagnosis and Monitoring of Chronic Myeloid Leukemia: Chiang Mai University Experience;Tantiworawit;Asian Pac J Cancer Prev,2016

3. Molecular biology of bcr-abl1-positive chronic myeloid leukemia;Quintás-Cardama;Blood,2009

4. New insights into the pathogenesis of chronic myeloid leukaemia: towards a path to cure;Thielen;Neth J Med,2011

5. Chinese chronic myeloid leukemia diagnosis and treatment guidelines (2011);Hematology Branch of the Chinese Medical Association;Chin J Hematol,2011

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of genomic RNA reference materials for BCR-ABL1 P210 measurement;Analytical and Bioanalytical Chemistry;2024-09-09

2. Analytical validation of the DropXpert S6 system for diagnosis of chronic myelocytic leukemia;Lab on a Chip;2024

3. Disease Response Assessment Modalities in Chronic Myeloid Leukemia: Past, Present, and Future;Indian Journal of Medical and Paediatric Oncology;2023-11-27

4. Liquid biopsies and minimal residual disease in lymphoid malignancies;Frontiers in Oncology;2023-05-09

5. Transferring measurable residual disease measurement in pediatric acute lymphoblastic leukemia from quantitative real‐time PCR to digital droplet PCR;Pediatric Transplantation;2023-02-07